Schedule 13G ownership disclosure

X4 Pharmaceuticals Inc

Common Stock, par value $0.001 per share · CUSIP: 98420X202

Event date: 2025-10-03

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Coastlands Capital LP

    Shares: 2,491,638.00 · Class: 9.99%

  • Coastlands Capital Partners LP

    Shares: 2,491,638.00 · Class: 9.99%

  • Coastlands Capital GP LLC

    Shares: 2,491,638.00 · Class: 9.99%

  • Coastlands Capital LLC

    Shares: 2,491,638.00 · Class: 9.99%

  • Matthew D. Perry

    Shares: 2,491,638.00 · Class: 9.99%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-096741
Form type
SCHEDULE 13G
Filer
Coastlands Capital LP
CIK
CIK 2068530
Filed
Oct 03, 2025
Reporting period
Oct 03, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub